Company Filing History:
Years Active: 2023-2024
Title: The Innovative Contributions of Derek Londesbrough
Introduction
Derek Londesbrough is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of psychiatric and neurological disorders. With a total of 4 patents to his name, Londesbrough's work is characterized by innovative compounds and methods that enhance therapeutic efficacy.
Latest Patents
Londesbrough's latest patents include groundbreaking inventions related to compounds of formula I. These compounds, or their pharmaceutically acceptable salts, are designed for use in treating psychiatric or neurological disorders. Notably, these compounds contain at least one deuterium atom at the α-position, which improves their oral bioavailability compared to α-diprotic analogues. Another significant patent involves the synthesis of N,N-dimethyltryptamine-type compounds. This patent describes the synthesis of compounds of Formula III from compounds of Formula I via compounds of Formula II, highlighting their potential uses in treating similar disorders.
Career Highlights
Throughout his career, Londesbrough has worked with various companies, including Small Pharma Ltd and Cybin UK Ltd. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical research.
Collaborations
Londesbrough has collaborated with notable individuals in his field, including Peter Rands and George Knight. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective projects.
Conclusion
Derek Londesbrough's contributions to the field of pharmaceuticals through his patents and collaborations underscore his role as a significant inventor. His work continues to impact the treatment of psychiatric and neurological disorders, showcasing the importance of innovation in healthcare.